Side effects profile in humans of (11)C-(+)-PHNO, a dopamine D(2/3) agonist ligand for PET.
Mizrahi
Romina
R
Houle
Sylvain
S
Vitcu
Irina
I
Ng
Alvina
A
Wilson
Alan A
AA
D006801:Humans; D008024:Ligands; D010078:Oxazines / Q000009:adverse effects* / Q000378:metabolism / Q000494:pharmacology; D049268:Positron-Emission Tomography; D017448:Receptors, Dopamine D2 / Q000819:agonists* / Q000378:metabolism*; D050637:Receptors, Dopamine D3 / Q000819:agonists* / Q000378:metabolism*; D012044:Regression Analysis
D008024:Ligands; D010078:Oxazines; D017448:Receptors, Dopamine D2; D050637:Receptors, Dopamine D3; C042631:naxagolide